annb0t
Top 20
ResMed Inc.âs RMD adjusted earnings per share (EPS) in the fourth quarter of fiscal 2024 were $2.08, up 30% year over year. The metric beat the Zacks Consensus Estimate by 2.5%.
The adjustments include certain non-recurring expenses/benefits like the amortization of acquired intangibles, restructuring and masks with magnet field safety notification expenses, among others.
GAAP EPS in the reported quarter was $1.98, up 26.9% from the year-ago quarter.
For the full year, the adjusted EPS o...
>>> Read more: ResMed's (RMD) Q4 Earnings Surpass Estimates, Margins Expand
The adjustments include certain non-recurring expenses/benefits like the amortization of acquired intangibles, restructuring and masks with magnet field safety notification expenses, among others.
GAAP EPS in the reported quarter was $1.98, up 26.9% from the year-ago quarter.
For the full year, the adjusted EPS o...
>>> Read more: ResMed's (RMD) Q4 Earnings Surpass Estimates, Margins Expand
